← Leaderboards
Jill C Fehrenbacher
Indiana University Indianapolis
$3,349,946
Attributed
$5,905,517
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2009–23$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,905,517 · 6
By mechanism
R01$4,415,267 · 2
R21$1,490,250 · 4
Top collaborators
- Mark R. Kelley10 shared
- Patrick L Sheets1 shared
- Michael R Vasko1 shared
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsAfferent NeuronsMediatingAttenuatedBehaviorPreventPainProteinsIn VivoBaseNociceptionAnimal ModelEndonucleaseRepairedCancer TherapyAffectQuality Of LifeSensoryPharmaceutical PreparationsDna DamageBase Excision RepairsDna RepairOxidation-ReductionMaintenance
Grant awards (15)
The Role of Calcitonin Gene-Related Peptide in rapidly progressive osteoarthritis induced by anti-nerve growth factor$198,125
R21 · FY2023 · AG · contact PI
(PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN)$451,597
R01 · FY2022 · CA · contact PI
The role of a lysosomal mechano-sensitive ion channel in pain$435,875
R21 · FY2022 · NS · contact PI
The Role of Calcitonin Gene-Related Peptide in rapidly progressive osteoarthritis induced by anti-nerve growth factor$237,750
R21 · FY2022 · AG · contact PI
(PQ9)Mechanistic Role of APE1 and BER in chemotherapy-induced peripheral neuropathy$537,592
R01 · FY2021 · CA
(PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN)$460,814
R01 · FY2021 · CA · contact PI
(PQ9)Mechanistic Role of APE1 and BER in chemotherapy-induced peripheral neuropathy$537,592
R01 · FY2020 · CA
(PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN)$460,814
R01 · FY2020 · CA · contact PI
(PQ9)Mechanistic Role of APE1 and BER in chemotherapy-induced peripheral neuropathy$521,463
R01 · FY2019 · CA
(PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN)$446,989
R01 · FY2019 · CA · contact PI
(PQ9)Mechanistic Role of APE1 and BER in chemotherapy-induced peripheral neuropathy$537,592
R01 · FY2018 · CA
(PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN)$460,814
R01 · FY2018 · CA · contact PI
DNA damage and repair in inflammation-induced peripheral sensitization$195,000
R21 · FY2016 · NS
THE ROLE FOR THE GPR30 RECEPTOR IN INFLAMMATORY PAIN$154,000
R21 · FY2010 · DE · contact PI
THE ROLE FOR THE GPR30 RECEPTOR IN INFLAMMATORY PAIN$269,500
R21 · FY2009 · DE · contact PI